Trial intelligence / Profile preview

MDR-001 in overweight or obesity (MOBILE)

NCT07274137Phase 3Not yet recruiting

Sponsor
MindRank
Start
Feb 2026
Primary completion
Jun 2027
Modality
Small Molecules
Countries
1
01

Overview

A Phase 3 trial of MDR-001 in obesity, sponsored by MindRank. Planned start Feb 2026; status: not yet recruiting.

02

Drugs

MDR-001
03

Conditions

obesity

Beyond the preview

Go deeper on NCT07274137.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT07274137.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call